The company provides a full range of development and contract manufacturing services to its customers, underpinned by excellent quality and a transparent customer experience.
Vibalogics is a privately owned contract development and manufacturing organization (CDMO) offering services for companies committed to developing therapeutic and prophylactic vaccines and biological products. With a specific focus on viruses, live bacteria and aseptic processing, we work in full compliance with international GMP standards in a BSL-2 classified state of the art facility in Germany.
With a modern facility and the basis for our operation built around provision of all activities for clinical drug development from feasibility assessment to product release, Vibalogics is perfectly positioned to manufacture your drug for the clinic.
Vibalogics offers process development, cGMP manufacturing and fill & finish of products for companies involved in the development of vaccines, gene therapies and oncolytic viral therapies in the biopharmaceutical industry.
Vibalogics places the greatest value on being a reliable partner and offering high quality services to the biopharmaceutical industry and works closely with pharmaceutical companies, Biotech. companies and academic institutions in Europe, the USA and the Asia-Pacific region. Our company distinguishes itself by being highly flexible, establishing and maintaining open communication lines and making the aims of our partners our own as well as always looking for creative business models to ensure we meet the budgetary expectations of our customers.
Privately owned and well financed, the company was originally set-up in 2002 to produce veterinary products based on viruses. The company continued to grow its operation by employing industry experts in development and manufacturing. In 2007, the company changed its name to Vibalogics and switched its main focus to the human health industry while still producing a number of veterinary products for its customers.